Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

ProMetic Life Sciences Inc T.PLI

Sector: Healthcare | Sub-Sector: Biotechnology

ProMetic Life Sciences Inc is a biopharmaceutical company offering technologies for drug purification, drug development, proteomics, and the elimination of pathogens.
Price: $2.46 | Change: +$0.01 | %Change: +0.41%
Volume: 1.4m | Day High/Low: 2.46/2.43 | 52 Week High/Low: 2.50/0.85
View modes: 
2 stars

RE:RE:We can all learn from this...

Thanks Balain  I just did a bit of a search between 2006 - 2012  posts of PLI  I think it applies to everyone at some point in time  when a person is losing money  and if you are 10x profit you shrug...read more
5 stars

RE:We can all learn from this...

Thanks Balain i guess we can learn a lot from that article.... The good news is....most of us longs would barely meet 1 of those critiera. we.ve weathered most storms, seen insider buying and selling...read more
1 star

OFF TOPIC "But A Very Good Read " SKYHIGH

"Phase-Appropriate" Drug Development The New "Time And Place" Contact The Supplier By Louis Garguilo, Executive Editor, Outsourced Pharma Follow Me On Twitter @Louis_Garguilo Parents today...read more
1 star

developing 'orphan' drugs to treat rare diseases Off Topic

Novel financing technique may unlock funding for developing 'orphan' drugs to treat rare diseases Published on February 28, 2015 at 5:01 AM · No Comments   inShare ...read more
5 stars

RE:4050 question?

I agree with Francois, they would carry on with other indications even if one turned out to be unsucessful. That being said I'm part of the group who believe the three phase 2 studies will succeed...read more
0 stars

RE:RE:RE:We can all learn from this...

The same could be said for the retail day trader vs. the retail investor. This is not a stock to day trade as much as it is an investment. The investor will most always realize bigger gains.  rate and reply
0 stars

RE:RE:We can all learn from this...

It's not that interesting....institutions are using other people's money.  Retail investors use their own hard earned dollars.  Everyone can be an ideal investor if they were using another's money and...read more
0 stars

RE:We can all learn from this...

Oh my, oh my...... It's so true! Conspiracy, leak, day trading, it's about what we see on the boards. And what about reactions to short terms events?  When I earlier posted about where are the...read more
5 stars

We can all learn from this...

Five reasons retail investors should act like institutions Republish Online Republish Offline Reprint Peter Hodson | February 27, 2015 12:53 PM ET   The average retail investor is...read more
1 star

RE:PPPS technology explained

How true even as I write this there may be 2 or 3 "PPPS" deals being worked on ! No wonder PL was smiling ear to ear in the latest video . skyhigh  rate and reply
5 stars

RE:4050 question?

I think they will and they should.... The 3 clinical trials will give datas on 3 different organs, the pancreas, kidneys and lung. As the mechanism of action of the fibrosis is complex, I think all...read more
1 star

RE:RE:Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug

C-peptide is formed naturally in the body, when insulin is cleaved from pro-insulin. Patients with type 1 diabetes, whose pancreases produce little or no insulin, are also susceptible to microvascular...read more
3 stars

RE:4050 question?

Fisher72 if you have watched the latest video with PL I think he answers a few of your questions skyhigh  rate and reply
0 stars

4050 question?

4050 is in clinical trials for several applications in several fibrotic organ diseases. Does PLI feel there is a strong common denominator in the different potential applications?. IE--if 4050 is not...read more
0 stars

RE:Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug

thanks  interesting gilaaaa  rate and reply
0 stars

RE:Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug

M80---you always bring great stuff to the table---good info and well explained---thanks  rate and reply
5 stars

Cebix Shuts Down Following Mid-Stage Trial of C-Peptide Drug

This might be interesting news for PLI : http://www.xconomy.com/san-diego/2015/02/23/cebix-shuts-down-following-mid-stage-trial-of-c-peptide-drug/ Cebix raised almost 50 millions $ since 2012 for...read more
0 stars

Suddenly the bashers are gone

That's the fun part of these boards, 5 weeks ago it was a disaster.  And by the way.... From oceaneleven...............and if you only think about losing time and not so much  money...................read more
3.5 stars

PPPS technology explained

Compare the plasma fractionnation with lights: Currently, the Cohn method is used, and look like this: Now, the PPPS : (OK, it was just for fun)  rate and reply
5 stars

RE:RE:RE:after hour trading

Bob, First, I like the emphasis on the russian deal. If you remember, even if I thought that deal was a very good one, there was a lot of whinning regarding this deal because the russians are not...read more